MAPT and atherosclerosis: The approach is being taken in AD by defining targets based on necessary and sufficient conditions to cause disease (increased cholesterol/atherosclerosis vs. amyloid/tau aggregation), and then treating with interventions that have large impacts on the target, at a stage of disease before downstream or end-organ damage occurs.